Literature DB >> 18337589

Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function.

Laura Davies1, Nirupama Karthikeyan, James T Lynch, Elin-Alia Sial, Areti Gkourtsa, Constantinos Demonacos, Marija Krstic-Demonacos.   

Abstract

Several posttranslational modifications including phosphorylation have been detected on the glucocorticoid receptor (GR). However, the interdependence and combinatorial regulation of these modifications and their role in GR functions are poorly understood. We studied the effects of c-Jun N-terminal kinase (JNK)-dependent phosphorylation of GR on its sumoylation status and the impact that these modifications have on GR transcriptional activity. GR is targeted for phosphorylation at serine 246 (S246) by the JNK protein family in a rapid and transient manner. The levels of S246 phosphorylation of endogenous GR increased significantly in cells treated with UV radiation that activates JNK. S246 GR phosphorylation by JNK facilitated subsequent GR sumoylation at lysines 297 and 313. GR sumoylation increased with JNK activation and was inhibited in cells treated with JNK inhibitor. GR sumoylation in cells with activated JNK was mediated preferentially by small ubiquitin-like modifier (SUMO)2 rather than SUMO1. An increase in GR transcriptional activity was observed after inhibition of JNK or SUMO pathways and suppression of GR transcriptional activity after activation of both pathways in cells transfected with GR-responsive reporter genes. Endogenous GR transcriptional activity was inhibited on endogenous target genes IGF binding protein (IGFBP) and glucocorticoid-induced leucine zipper (GILZ) when JNK and SUMO pathways were induced individually or simultaneously. Activation of both of these signals inhibited GR-mediated regulation of human inhibitor of apoptosis gene (hIAP), whereas simultaneous activation had no effect. We conclude that phosphorylation aids GR sumoylation and that cross talk of JNK and SUMO pathways fine tune GR transcriptional activity in a target gene-specific manner, thereby modulating the hormonal response of cells exposed to stress.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337589      PMCID: PMC5419542          DOI: 10.1210/me.2007-0360

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  47 in total

Review 1.  Nuclear receptor coregulators: cellular and molecular biology.

Authors:  N J McKenna; R B Lanz; B W O'Malley
Journal:  Endocr Rev       Date:  1999-06       Impact factor: 19.871

2.  Direct and distinguishable inhibitory roles for SUMO isoforms in the control of transcriptional synergy.

Authors:  Sam Holmstrom; Mary E Van Antwerp; Jorge A Iñiguez-Lluhi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

Review 3.  Transcriptional regulation by the MAP kinase signaling cascades.

Authors:  Shen-Hsi Yang; Andrew D Sharrocks; Alan J Whitmarsh
Journal:  Gene       Date:  2003-11-27       Impact factor: 3.688

4.  p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.

Authors:  Aaron L Miller; M Scott Webb; Alicja J Copik; Yongxin Wang; Betty H Johnson; Raj Kumar; E Brad Thompson
Journal:  Mol Endocrinol       Date:  2005-04-07

5.  Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids.

Authors:  A D Wallace; J A Cidlowski
Journal:  J Biol Chem       Date:  2001-09-12       Impact factor: 5.157

6.  Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by a C-terminal-associated protein phosphatase.

Authors:  Zhen Wang; Weiwei Chen; Evelyn Kono; Thoa Dang; Michael J Garabedian
Journal:  Mol Endocrinol       Date:  2006-12-21

7.  Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation.

Authors:  M Itoh; M Adachi; H Yasui; M Takekawa; H Tanaka; K Imai
Journal:  Mol Endocrinol       Date:  2002-10

8.  Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress.

Authors:  Tomoshige Kino; Takamasa Ichijo; Niranjana D Amin; Sashi Kesavapany; Yonghong Wang; Nancy Kim; Sandesh Rao; Audrey Player; Ya-Li Zheng; Michael J Garabedian; Ernest Kawasaki; Harish C Pant; George P Chrousos
Journal:  Mol Endocrinol       Date:  2007-04-17

9.  Differential effect of small ubiquitin-like modifier (SUMO)-ylation of the androgen receptor in the control of cooperativity on selective versus canonical response elements.

Authors:  L Callewaert; G Verrijdt; A Haelens; F Claessens
Journal:  Mol Endocrinol       Date:  2004-03-18

10.  Potentiation of glucocorticoid receptor transcriptional activity by sumoylation.

Authors:  Yves Le Drean; Nathalie Mincheneau; Pascale Le Goff; Denis Michel
Journal:  Endocrinology       Date:  2002-09       Impact factor: 4.736

View more
  51 in total

1.  Glucocorticoid receptors, epidermal homeostasis and hair follicle differentiation.

Authors:  Paloma Pérez
Journal:  Dermatoendocrinol       Date:  2011-07-01

2.  Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats.

Authors:  Leandro F Vendruscolo; Estelle Barbier; Joel E Schlosburg; Kaushik K Misra; Timothy W Whitfield; Marian L Logrip; Catherine Rivier; Vez Repunte-Canonigo; Eric P Zorrilla; Pietro P Sanna; Markus Heilig; George F Koob
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

Review 3.  Minireview: latest perspectives on antiinflammatory actions of glucocorticoids.

Authors:  Karolien De Bosscher; Guy Haegeman
Journal:  Mol Endocrinol       Date:  2008-12-18

Review 4.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

Review 5.  The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.

Authors:  Ioanna Petta; Lien Dejager; Marlies Ballegeer; Sam Lievens; Jan Tavernier; Karolien De Bosscher; Claude Libert
Journal:  Microbiol Mol Biol Rev       Date:  2016-05-11       Impact factor: 11.056

6.  MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies.

Authors:  Ronit Vogt Sionov
Journal:  ISRN Hematol       Date:  2013-01-29

7.  Small ubiquitin-like modifier 3-modified proteome regulated by brain ischemia in novel small ubiquitin-like modifier transgenic mice: putative protective proteins/pathways.

Authors:  Wei Yang; Huaxin Sheng; J Will Thompson; Shengli Zhao; Liangli Wang; Pei Miao; Xiaozhi Liu; M Arthur Moseley; Wulf Paschen
Journal:  Stroke       Date:  2014-02-25       Impact factor: 7.914

8.  SUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoR.

Authors:  Benoit Pourcet; Inés Pineda-Torra; Bruno Derudas; Bart Staels; Corine Glineur
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

9.  Transactivation of Herpes Simplex Virus 1 (HSV-1) Infected Cell Protein 4 Enhancer by Glucocorticoid Receptor and Stress-Induced Transcription Factors Requires Overlapping Krüppel-Like Transcription Factor 4/Sp1 Binding Sites.

Authors:  Jeffery B Ostler; Prasanth Thunuguntla; Bailey Y Hendrickson; Clinton Jones
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

10.  Acute or chronic stress induce cell compartment-specific phosphorylation of glucocorticoid receptor and alter its transcriptional activity in Wistar rat brain.

Authors:  Miroslav Adzic; Jelena Djordjevic; Ana Djordjevic; Ana Niciforovic; Constantinos Demonacos; Marija Radojcic; Marija Krstic-Demonacos
Journal:  J Endocrinol       Date:  2009-04-30       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.